Zobrazeno 1 - 10 of 85 pro vyhledávání: '"Migranya"'
1
Migraine, inflammatory bowel disease and celiac disease: A Mendelian randomization study
Autor: Welander, Nike Zoe, Rukh, Gull, Rask-Andersen, Mathias, Ligthart, Lannie, Hottenga, Jouke Jan, Penninx, Brenda W.J.H., Posthuma, Danielle, Boomsma, Dorret I., van den Maagdenberg, Arn M.J.M., Schiöth, Helgi Birgir, Mwinyi, Jessica
Publikováno v: Headache, 63(5), 642-651. Wiley-Blackwell
Welander, N Z, Rukh, G, Rask-Andersen, M, Ligthart, L, Hottenga, J J, Penninx, B W J H, Posthuma, D, Boomsma, D I, van den Maagdenberg, A M J M, Schiöth, H B, Mwinyi, J & The International Headache Genetics Consortium 2023, ' Migraine, inflammatory bowel disease and celiac disease : A Mendelian randomization study ', Headache, vol. 63, no. 5, pp. 642-651 . https://doi.org/10.1111/head.14470
The International Headache Genetics Consortium 2023, ' Migraine, inflammatory bowel disease and celiac disease : A Mendelian randomization study ', Headache, vol. 63, no. 5, pp. 642-651 . https://doi.org/10.1111/head.14470
Objective: To assess whether migraine may be genetically and/or causally associated with inflammatory bowel disease (IBD) or celiac disease. Background: Migraine has been linked to IBD and celiac disease in observational studies, but whether this lin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b32e5dde8d2b33e1f38f8cd68d4360e
https://doi.org/10.1111/head.14470
Zobrazit plný text záznamu
2
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial
Autor: Lipton, Richard B., Pozo-Rosich, Patricia, Blumenfeld, Andrew M., Li, Ye, Severt, Lawrence, Stokes, Jonathan T., Creutz, Lela, Gandhi, Pranav, Dodick, David, Universitat Autònoma de Barcelona
Publikováno v: Scientia
Background and ObjectivesThe oral calcitonin gene–related peptide receptor antagonist atogepant is indicated for the preventive treatment of episodic migraine. We evaluated changes in patient-reported outcomes with atogepant in adults with migraine
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::236f594dcf434fe439ea76ee5bdc825f
https://doi.org/10.1212/wnl.0000000000201568
Zobrazit plný text záznamu
4
Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study
Autor: Patricia Pozo-Rosich, Holland C. Detke, Shufang Wang, David Doležil, Lily Q. Li, Sheena K. Aurora, Uwe Reuter
Publikováno v: Scientia
Galcanezumab; Chronic migraine; Preventive treatment Galcanezumab; Migraña crónica; Tratamiento preventivo Galcanezumab; Migranya crònica; Tractament preventiu Background Galcanezumab, a monoclonal antibody to calcitonin gene-related peptide, was
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3445338f363b3d64be27fa84f4c0fe5
https://doi.org/10.1080/03007995.2022.2059975
Zobrazit plný text záznamu
5
A study of differential microRNA expression profile in migraine: the microMIG exploratory study
Autor: Gallardo, V. J., Gómez-Galván, J. B., Asskour, L., Torres-Ferrús, Marta, Alpuente, Alicia, Caronna, Edoardo, Pozo-Rosich, Patricia, Universitat Autònoma de Barcelona
Publikováno v: Scientia
Background Several studies have described potential microRNA (miRNA) biomarkers associated with migraine, but studies are scarcely reproducible primarily due to the heterogeneous variability of participants. Increasing evidence shows that disease-rel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb27f24f9a28f5884d832805b500d02
https://hdl.handle.net/11351/9150
Zobrazit plný text záznamu
6
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
Autor: Edoardo Caronna, Thomas C van den Hoek, Hayrunnisa Bolay, David Garcia-Azorin, Ana Beatriz Gago-Veiga, Massimiliano Valeriani, Tsubasa Takizawa, Karl Messlinger, Robert E Shapiro, Peter J Goadsby, Messoud Ashina, Cristina Tassorelli, Hans-Christoph Diener, Gisela M Terwindt, Patricia Pozo-Rosich
Publikováno v: Caronna, E, van den Hoek, T C, Bolay, H, Garcia-Azorin, D, Gago-Veiga, A B, Valeriani, M, Takizawa, T, Messlinger, K, Shapiro, R E, Goadsby, P J, Ashina, M, Tassorelli, C, Diener, H C, Terwindt, G M & Pozo-Rosich, P 2022, ' Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic : A comprehensive review ', Cephalalgia : an international journal of headache, vol. 43, no. 1, pp. 1-18 . https://doi.org/10.1177/03331024221131337
Scientia
Objective The objective is to summarize the knowledge on the epidemiology, pathophysiology and management of secondary headache attributed to SARS-CoV-2 infection and vaccination; as well as to delineate their impact on primary headache disorders. Me
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caf32b846d5e398febb283df40edab9f
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/21231
Zobrazit plný text záznamu
7
Migraine molecular phenotyping through the study of the calcitonin gene-related peptide : towards precision medicine
Autor: Alpuente Ruiz, Alicia
S'estableix que el pèptid relacionat amb el gen de la calcitonina (CGRP) juga un paper essencial en la fisiopatologia de la migranya i que el bloqueig del CGRP es una revolució en el tractament preventiu de la migranya amb resultats clínics excel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1404::fb6f4e5790a2ee2856f2801be641bc26
https://ddd.uab.cat/record/281016
Zobrazit plný text záznamu
8
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies
Autor: Patricia, Pozo-Rosich, David W, Dodick, Anders, Ettrup, Joe, Hirman, Roger, Cady
Publikováno v: Scientia
Efficacy; Eptinezumab; Prevention Eficacia; Eptinezumab; Prevención Eficàcia; Eptinezumab; Prevenció Background Monthly headache frequency directly correlates with personal/societal burden and impacts severity and preventive treatment decisions. T
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c982d946521c570c45fcaae1b146297
https://doi.org/10.1186/s12883-022-02914-9
Zobrazit plný text záznamu
9
Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18FDG-PET and MRI study
Autor: Carles Lorenzo-Bosquet, Joan Castell-Conesa, Patricia Pozo-Rosich, Alicia Alpuente, Victor José Gallardo, Deborah Pareto, Adrià Vilà-Balló, Marta Torres-Ferrus, Edoardo Caronna, Alex Rovira, Gemma Cuberas-Borrós
Publikováno v: The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-11 (2021)
The Journal of Headache and Pain
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
Background To describe interictal brain structural and metabolic differences between patients with episodic migraine (EM), chronic migraine (CM) and healthy controls (HC). Methods This is an exploratory study including right-handed age-matched women
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a424ac0a820bbcd9c9edfff019e331
https://doaj.org/article/aa7f0df0ff1843b29c866f6381ad2fd5
Zobrazit plný text záznamu
10
Editorial: Lifestyle modifications to manage migraine
Autor: Yohannes W, Woldeamanuel, Surya, Shrivastava, Marta, Vila-Pueyo
Publikováno v: Scientia
Headache; Lifestyle and behavior; Migraine Dolor de cabeza; Estilo de vida y comportamiento; Migraña Mal de cap; Estil de vida i comportament; Migranya YW received research funding from the NINDS (National Institute of Neurological Disorders and Str
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8bb4761f07196a68c0049e0296dd217
https://hdl.handle.net/11351/8464
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje